Profil
Tanya Fischer, formerly Head of Translational Medicine at Alnylam Pharmaceuticals, Inc., and Associate Professor at Yale University, also served as the Chief Development Officer at Biohaven Ltd.
from 2022 to 2023.
Anciens postes connus de Tanya Fischer
| Sociétés | Poste | Fin |
|---|---|---|
| BIOHAVEN LTD. | Corporate Officer/Principal | 01/10/2023 |
| Yale University | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
3
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| BIOHAVEN LTD. | Health Technology |
